Menu
Recruiting NCT03934112

Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit

— Observational Transfusion Related Complication

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Transfusion Related Complication. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care

Overview

This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria. These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies. It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.

Primary outcome measures

  • Survival at 90 days after leaving ICU [Time frame: Day 90]

Eligibility criteria

Inclusion criteria

  • Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered
  • Patient admitted between 1st January 2012 to 31st December 2017

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 1 center
  • CHU de Besançon — Besançon

Identifiers

NCT: NCT03934112 · API/2016/72

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗